GWM
IOVA icon

GK Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History

GK Wealth Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$107K Buy
+7,196
New +$51.5K 0.06% 282

Other funds holding IOVA

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
HCG
Haven Capital Group Westlake Village, California $131M AUM 23.95% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $937M AUM 18.56% 1-Year Est. Return

GK Wealth Management's IOVA Position: Q3 2026 in Review

GK Wealth Management opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 7,196 shares worth $107K. The stake represents 0.06% of the portfolio and ranks #282 among its holdings.

7 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • GK Wealth Management held 7,196 shares of Iovance Biotherapeutics worth $107K as of Q3 2026.
  • Iovance Biotherapeutics was a new GK Wealth Management position in Q3 2026.
  • Iovance Biotherapeutics made up 0.06% of GK Wealth Management's portfolio in Q3 2026, its #282 holding.
  • 7 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.